During mouse embryonic development, oocytes develop in germline cysts, formed by several rounds of cell division followed by incomplete cytokinesis. Shortly after birth, cysts break down and individual oocytes are enclosed by granulosa cells to form primordial follicles. At the same time, two-thirds of the oocytes die by apoptosis with only one-third surviving. We have previously shown that the steroid hormones, estradiol (E2), and progesterone as well as the phytoestrogen genistein can inhibit cyst breakdown and primordial follicle assembly. However, the mechanisms by which steroid hormones regulate oocyte cyst breakdown and selective oocyte survival are unknown. Here, we confirmed the expression of estrogen receptor (ER) mRNA and protein in neonatal mouse ovaries using reverse transcriptase-PCR, western blotting, and immunocytochemistry. We then used ER-specific agonists and antagonists to understand the mechanism of estrogen signaling. 4,4′,4″-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol, an ERα-selective agonist, and 2,3-bis(4-hydroxyphenyl)-propionitrile, an ERβ-selective agonist, both inhibited cyst breakdown in organ culture, suggesting that E2 can signal through both the receptors to regulate cyst breakdown. ICI 182,780, an ER antagonist, completely blocked E2's action. 1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride, an ERα-specific antagonist, fully blocked E2's effect on oocyte cyst breakdown and primordial follicle assembly and (R,R)-5,11-diethyl-5,6,11,12-tetrahydro-2,8-chrysenediol, an ERβ-specific antagonist, partially blocked E2, further supporting the idea that both receptors are involved in estrogen signaling in neonatal oocyte development. E2 conjugated to BSA, which can only exert effects at the membrane, was able to inhibit cyst breakdown, implying that E2 could also function through a membrane-bound ER to regulate cyst breakdown.
Low expression of SEMA6C accelerates the primordial follicle activation in the neonatal mouse ovary
